Header cover image
  • Investing Ideas
  • Finnish Pharmaceuticals & Biotech Undervalued over 20% based on DCF

Finnish Pharmaceuticals & Biotech Undervalued over 20% based on DCF

Results

1

0 new

Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.

1 companies

Orion Oyj

Market Cap: €10.2b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

ORNBV

€73.10

7D

2.0%

1Y

52.5%